Antiviral activities and pharmacokinetics of penciclovir and famciclovir in Pekin ducks chronically infected with duck hepatitis B virus

Antiviral Chemistry and Chemotherapy

Volumn 7, Issue 3, 1996, Pages 153-159

  Tsiquaye, K N ^a   Sutton, D ^b   Maung, M ^a   Boyd, M R ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

antiviral; famciclovir; hepatitis; penciclovir

Indexed keywords

DNA POLYMERASE; FAMCICLOVIR; MARKER; PENCICLOVIR; VIRUS DNA; VIRUS ENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD LEVEL; CHRONIC HEPATITIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DUCK; HEPATITIS B; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VIRUS REPLICATION;

EID: 0029924230     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029600700305     Document Type: Article

References (34)

1. Alexander, G.J.M., Fagan, E.A., Hegarty, J.E., Yeo, J., Eddleston, A.L.W.F., and Williams, R. (1987) Controlled clinical trial of acyclovir in chronic hepatitis B virus infection. J Med Virol 21: 81-87.
2. Bacon, T.H., and Schinazi, R.F. (1993) Contrasts and similarities between the activity of penciclovir and acyclovir against HSV and VZV in cell culture. Antiviral Chem Chemother 4 (suppl. 1): 25-36.
3. Beasley, R.P., and Hwang, L.Y. (1984) Epidemiology of heptocellular carcinoma In Viral Hepatitis and Liver Disease. Vyas, G.N., Dienstag, J.L., Hoofnagle, J.H. (eds). New York:Grune and Stratton, pp. 209-224.
4. Boyd, M.R., Bacon, T.H., Sutton, D., and Cole, M. (1987) Anti-herpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) in cell culture Antimicrob Agents Chemother 31: 1238-1248.
5. Boyd, M.R., Safrin, S., and Kern, E.R. (1993) Penciclovir: A review of its spectrum of activity, selectivity and cross-resistance pattern Antiviral Chem Chemother 4 (suppl. 1): 3-11.
6. Civitico, G., Wang, Y., Luscombe, C., Bishop, N., Tachedjian, G., Gust, I., and Locarnini, S. (1990) Antiviral Strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds. J Med Virol 31: 90-97.
7. Earnshaw, D.C., Bacon, T.H., Darlison, S.J., Edmonds, K., Perkins, R.M., and Vere Hodge, R.A. (1992) Penciclovir: mode of action of penciclovir in MRC-5 cells infected with herpes simplex virus (HSV-1), HSV-2 and varicella-zoster virus. Antimircrob Agents Chemother 36: 2747-2757.
8. Field, H.J., Tewari, D., Sutton, D., Thackray, A.M. (1995) Comparison of efficacies of famciclovir and valaciclovir against herpes simplex virus type 1 in a murine immunosuppression model. Antimicrob Agents Chemother 39: 1114-1119.
9. Field, H.J., and Thackray, A.M. (1995) The effects of delayed-onset chemotherapy using famciclovir or valaciclovir in a murine immunosuppression model for HSV-1. Antiviral Chem Chemother 6: 210-216.
10. Hantz, D., Ooka, T., Vitvitski, L., Pichoud, C., and Trepo, C. (1984) Comparison of properties of woodchuck hepatitis virus and human hepatitis B virus endogenous DNA polymerases. Antimicrob Agents Chemother 25: 242-246.
11. Hamden, M.R., and Jarvest, R.L. (1985) An improved synthesis of the antiviral acyclonucleoside 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine. Tetrahedron Lett 26: 4265-4268.
12. Hamden, M.R., Jarvest, R.L., Boyd, M.R., Sutton, D., and Vere Hodge, R.A. (1989) Prodrugs of the selective antiherpesvirus agent 9-[4-hydroxy-3- (hydroxymethyl)but-1-yl]guanine (BRL 39123) with improved absorption properties. J Med Chem 32: 1738-1743.
13. Hirota, K., Sherker, A.H., Omata, M., Yokosuka, O., and Okuda, K. (1987) Effects of adenine arabinoside on serum and intrahepatic replicative forms of duck hepatitis in chronic infection. Hepatology 7: 24-28.
14. Hoofnagle, J.H., Shafntz, D.A., and Popper, A. (1987) Chronic type B hepatitis and the healthy HBsAg carrier state. Hepatology 7: 758-763.
15. Jacyna, M.R., and Thomas, H.C. (1990) Antiviral therapy: Hepatitis B. Br Med Bull 46: 368-382.
16. Kassianides, C., Hoofnagle, J.H., Miller, R.H., Doo, E., Ford, H., Broder, S., and Mitsuya, H. (1989) Inhibition of duck hepatitis B virus replication by 2′,3′-dideoxycytidine: a potent inhibitor of reverse transcriptase. Gastroenterology 97: 1275-1280.
17. Keller, P.M., McKee, S.A., and Fyfe, J.A. (1985) Cytoplasmic 5′-nucleotidase catalyzes acyclovir phosphorylation. J Biol Chem 260: 8664-8667.
18. King, M.G.W. (1988) Low cost vaccine fights hepatitis B. International Health News 9:1.
19. Lee, B., Luo, W., Suzuki, S., Robins, M., and Tyrell, D.L. (1989) In vitro and in vivo comparison of the abilities of purine and pyrimidine 2′, 3′-dideoxynucleosides to inhibit duck hepadnavirus. Antimicrob Agents Chemother 33: 336-339.
20. Marion, P.L. (1988) Use of animal models to study HBV. Prog Med Virol 35: 43-75.
21. Popper, H., Shafritz, D.A., and Hoofnagle, J.H. (1987) Relation of the hepatitis B carrier state to hepatcellular carcinoma. Hepatology 7: 764-772.
22. Pue, M.A., and Benet, L.Z. (1993) Pharmacokinetics of famiclovir in man. Antiviral Chem Chemother 4 (suppl. 1): 47-55.
23. Shaw, T., Amor, P., Civitico, G., Boyd, M.R., and Locarnini, S.A. (1994) In vitro antiviral activity activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus. Antimicrob Agents Chemother 38: 719-723.
24. Smee, D.F., Knight, S.S., Duke, A.E., Robinson, W.S., Mathews, T.R., and Marion, P.L. (1985) Activities of arabinosyladenine monophosphate and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine against ground squirrel virus in vivo as determined by reduction in serum virion-associated DNA polymerase. Antimicrob Agents Chemother 27: 277-279.
25. Standring-Cox, R., Bacon, T.H., Howard, B.A., Gilbart, J., and Boyd, M.R. (1994) Prolonged activity of penciclovir in cell culture against varicella-zoster virus. Antiviral Res 23 (suppl. 1): 96.
26. Sutton, D., and Boyd, M.R. (1993) Comparative activity of penciclovir and acyclovir in mice infected intraperitoneally with HSV-1 SC16. Antimicrob Agents Chemother 37: 642-645.
27. Sutton, D., and Kern, E.R. (1993) Activity of penciclovir and famciclovir in HSV-infected animals: a review. Antiviral Chem Chemother 4 (suppl 1): 37-46.
28. Thackray, A.M., and Field, H. J. (1996) Comparison of the effects of famciclovir and valaciclovir on the pathogenisis of herpes simplex virus type 2 in a murine infection model. Antimicrob Agents Chemother 40: (4) 291-299.
29. Tsiquaye, K.N., McCaul, T.F., and Zuckerman, A.J. (1985) Maternal transmission of duck hepatitis B virus in pedigree Pekin ducks. Hepatology 5: 662-668.
30. Tsiquaye, K.M., Collins, P., and Zuckerman, A.J. (1986) Antiviral activity of the polybasic anion. suramin and acyclovir in Hepadna virus infection. J Antimicrob Chemother 18 (suppl. B): 223-228.
31. Tsiquaye, K.N., Slomka, M.J., and Maung, M. (1994) Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo. J Med Virol 42: 306-310.
32. Vere Hodge, R.A., and Cheng, Y.-C. (1993) The mode of action of penciclovir. Antiviral Chem Chemother 4 (suppl. 1): 13-24.
33. Vere Hodge, R.A., and Perkins, R.M. (1989) Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells. Antimicrob Agents Chemother 33: 223-229.
34. Vere Hodge, R.A., Sutton, D., Boyd, M.R., Harden, M.R., and Jarvest, R.L. (1989) Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine; penciclovir]. Antimicrob Agents Chemother 33: 1765-1773.